Cutler Group’s Bio-Techne TECH Stock Holding History

Cutler Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,000	Closed	-$6K	–	4869
2020 Q1	$6K	Buy	+4,000	New	+$200K	﹤0.01%	3015

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cutler Group's TECH Position: Q4 2020 in Review

Cutler Group sold out of Bio-Techne (TECH) in Q4 2020, closing a stake of 800 shares — an estimated $49K sold.

Cutler Group first reported a position in TECH in Q1 2018 and held it in 4 quarters. The position peaked at $90K in Q1 2018. 441 funds tracked by Wall St. Rank hold TECH as of Q4 2020.

Cutler Group reported no remaining Bio-Techne position as of Q4 2020 after selling out during the quarter.
Cutler Group sold 800 Bio-Techne shares in Q4 2020, an estimated $49K.
Cutler Group first reported a position in Bio-Techne in Q1 2018 and held it in 4 quarters.
Cutler Group's Bio-Techne position peaked at $90K in Q1 2018.
441 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.